LaraƱo, Chamy .
HRN: 27-04-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2025
CEFUROXIME 1.5GM (VIAL)
05/16/2025
05/23/2025
IVT
1.5gm
Q 8 HRS
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes